http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GE-P19970764-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fd34fea6801ea1d9286475b96be2d26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 1993-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce3f998661a076d4897aa27a5b282e97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6edc08a42e825e31660ae1d1d01c260f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243cbd258e333bcf5b2a0e32e064b3d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c372875dda6c9872b7a16a437cacd4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6884895d16b19ffdb46d03724eb78be |
| publicationDate | 1997-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GE-P19970764-B |
| titleOfInvention | Solid Medicinal Form of Iphosphamide |
| abstract | This invention refers to the sphere of medicine, in particular to the solid medicinal preparation for oral administration, which as an active substance comprises iphosphamide-3-(2-chlorethyl)-2-(chlorethyl-amino)-tetrahydro-2H,1,2,2-oxazophosphorine-2-oxid. The essence of the invention is in, that the solid medicinal form of iphosphamide for filling the solid gellatine capsules comprises (w.p) active substance and microcrystal cellulose in respect 1-0,2:4, and the tablets (w.p)-1,0 iphosphamide, 0,1-1,0 trisubstituted calcium phosphate and 0,04-0,4 polyethylen glycole and 5-60 slipping, 1-10-loosening, 0,1-10-lubricating and 0,10-80 binding auxilliary substances on account of the tablet weight (weight %). |
| priorityDate | 1990-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.